Finance

Lists
6541:TPE
Tanvex Biopharma Inc
31,05 NT$
-0,16%
(-0,050) 1D
21 ოქტ, 13:30:32 GMT+8  ·   TWD
All symbols
SymbolPriceChange% Change
Generating top insights for 6541...
Open
31,75 NT$
High
31,80 NT$
Low
30,90 NT$
Mkt. cap
8,23 მლრდ.
Avg. vol.
464,52 ათ.
Volume
345,41 ათ.
52-wk high
65,50 NT$
52-wk low
29,60 NT$
EPS
-5,56 NT$
Shares outstanding
242,67 მლნ.
No. of employees
215
Open
31,75 NT$
High
31,80 NT$
Low
30,90 NT$
Mkt. cap
8,23 მლრდ.
Avg. vol.
464,52 ათ.
Volume
345,41 ათ.
52-wk high
65,50 NT$
52-wk low
29,60 NT$
EPS
-5,56 NT$
Shares outstanding
242,67 მლნ.
No. of employees
215
News stories
From web sources and news partners
About Tanvex Biopharma Inc
CEO-
Employees215
Founded2011
Headquarters-
Sector-
Websitetanvex.com
Previous reportsAll values in TWD
Loading Previous Earnings...
Revenue
Net income
All values in TWD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
125,34 მლნ.
178,95 მლნ.
132,83 მლნ.
220,44 მლნ.
Cost of goods sold
287,65 მლნ.
422,66 მლნ.
399,36 მლნ.
446,37 მლნ.
Cost of revenue
287,65 მლნ.
422,66 მლნ.
399,36 მლნ.
446,37 მლნ.
Research and development expenses
19,27 მლნ.
13,26 მლნ.
24,24 მლნ.
19,86 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
104,56 მლნ.
104,26 მლნ.
108,51 მლნ.
121,17 მლნ.
Operating expense
123,98 მლნ.
129,86 მლნ.
133,70 მლნ.
141,15 მლნ.
Total operating expenses
411,63 მლნ.
552,52 მლნ.
533,06 მლნ.
587,52 მლნ.
Operating income
-286,29 მლნ.
-373,57 მლნ.
-400,23 მლნ.
-367,07 მლნ.
Other non operating income
-372,00 ათ.
44,99 მლნ.
188,00 ათ.
418,00 ათ.
EBT including unusual items
-273,50 მლნ.
-420,53 მლნ.
-388,70 მლნ.
-382,53 მლნ.
EBT excluding unusual items
-294,27 მლნ.
-305,62 მლნ.
-388,70 მლნ.
-382,53 მლნ.
Income tax expense
-
3,00 ათ.
27,00 ათ.
1,00 ათ.
Effective tax rate
-
-
-0,01%
-
Other operating expenses
-
-
-
-
Net income
-273,50 მლნ.
-420,54 მლნ.
-388,72 მლნ.
-382,53 მლნ.
Net profit margin
-218,21%
-235,00%
-292,65%
-173,53%
Earnings per share
-
-
-
-
Interest and investment income
7,83 მლნ.
11,66 მლნ.
6,03 მლნ.
5,01 მლნ.
Interest expense
-11,41 მლნ.
-11,31 მლნ.
-11,70 მლნ.
-16,53 მლნ.
Net interest expenses
-3,58 მლნ.
354,00 ათ.
-5,67 მლნ.
-11,52 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-243,08 მლნ.
-370,64 მლნ.
-357,68 მლნ.
-326,85 მლნ.
Gain or loss from assets sale
-21,83 მლნ.
62,12 მლნ.
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები